Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT04956146 · UNKNOWN
Trial details
- NCT number
- NCT04956146
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2023-09-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.